The application strategy of liposomes in organ targeting therapy
Z Xun, T Li, X Xue - Wiley Interdisciplinary Reviews …, 2024 - Wiley Online Library
Liposomes—microscopic phospholipid bubbles with bilayered membrane structure—have
been a focal point in drug delivery research for the past 30 years. Current liposomes …
been a focal point in drug delivery research for the past 30 years. Current liposomes …
Preparation of cellulose-based nanoparticles via electrostatic self-assembly for the pH-responsive delivery of astaxanthin
M Gan, A Cao, L Cai, X Xiang, J Li, Q Luan - Food Chemistry, 2025 - Elsevier
Oral administration of astaxanthin (AST), a potent antioxidant, is limited owing to its low
solubility, physicochemical stability, and bioavailability. This study developed pH-responsive …
solubility, physicochemical stability, and bioavailability. This study developed pH-responsive …
Edoxaban enfolded beta-1,4-poly-d-glucosamine nanoparticles for targeting eponym Stuart–Prower factor for treatment of venous thrombosis
P Pazhani, JP Dharmian, S Arumugam… - Journal of Drug …, 2024 - Taylor & Francis
The present research looked for ways to develop shielded nanoparticles (NPs)-drug
transporters made of chitosan (CS) to enhance the bioavailability of edoxaban tosylate …
transporters made of chitosan (CS) to enhance the bioavailability of edoxaban tosylate …
Formulation, Optimization, In-Vitro and In-Vivo Evaluation of Nateglinide-Loaded Nanostructured Lipid Carriers for Enhanced Bioavailability
SS Tiwari, YD Dange, SM Honmane, MG Saralaya… - BioNanoScience, 2025 - Springer
Nateglinide (NTG) belongs to the meglitinide class, an oral hypoglycemic agent used in the
treatment of insulin-resistant (Type II) diabetes mellitus. Potential constraints associated with …
treatment of insulin-resistant (Type II) diabetes mellitus. Potential constraints associated with …
Enzalutamide Loaded Folic Acid Decorated Mesoporous Silica Nanoparticles for Targeted Drug Delivery for Prostate Cancer Management
K Parmar, S Bhatt - Journal of Inorganic and Organometallic Polymers and …, 2024 - Springer
The present work was focussed on the fabrication and development of folic acid conjugated
mesoporous nanoparticulate system (FMSNs) of enzalutamide (EFMSNs) for the targeted …
mesoporous nanoparticulate system (FMSNs) of enzalutamide (EFMSNs) for the targeted …
Formulation Optimization and Evaluation of Patented Solid Lipid Nanoparticles of Ambrisentan for Pulmonary Arterial Hypertension
H Shewale, A Kanugo - Recent Patents on Nanotechnology, 2024 - benthamdirect.com
Background Ambrisentan is a new endothelin receptor antagonist extensively used to
manage pulmonary or pulmonary arterial hypertension. Objective The therapeutic efficacy of …
manage pulmonary or pulmonary arterial hypertension. Objective The therapeutic efficacy of …